Published in Antiviral Res on February 26, 2014
Clinical Trial of Favipiravir Treatment of Patients With COVID-19 | NCT04600999
Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea. PLoS Med (2016) 2.88
Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys. Nature (2016) 1.38
Identification of 53 compounds that block Ebola virus-like particle entry via a repurposing screen of approved drugs. Emerg Microbes Infect (2014) 1.18
Human Ebola virus infection in West Africa: a review of available therapeutic agents that target different steps of the life cycle of Ebola virus. Infect Dis Poverty (2014) 0.94
Favipiravir elicits antiviral mutagenesis during virus replication in vivo. Elife (2014) 0.93
Antiviral therapies against Ebola and other emerging viral diseases using existing medicines that block virus entry. F1000Res (2015) 0.92
Backs against the wall: novel and existing strategies used during the 2014-2015 Ebola virus outbreak. Clin Microbiol Rev (2015) 0.92
Ebola: a holistic approach is required to achieve effective management and control. J Allergy Clin Immunol (2015) 0.92
Small molecules with antiviral activity against the Ebola virus. F1000Res (2015) 0.90
Development and Characterization of a Guinea Pig-Adapted Sudan Virus. J Virol (2015) 0.90
Approved Antiviral Drugs over the Past 50 Years. Clin Microbiol Rev (2016) 0.88
A Rapid Screening Assay Identifies Monotherapy with Interferon-ß and Combination Therapies with Nucleoside Analogs as Effective Inhibitors of Ebola Virus. PLoS Negl Trop Dis (2016) 0.87
Efficacy of T-705 (Favipiravir) in the Treatment of Infections with Lethal Severe Fever with Thrombocytopenia Syndrome Virus. mSphere (2016) 0.87
Alterations in favipiravir (T-705) pharmacokinetics and biodistribution in a hamster model of viral hemorrhagic fever. Antiviral Res (2015) 0.86
Federal funding in support of Ebola medical countermeasures R&D. Health Secur (2015) 0.85
Structural Analysis of Monomeric RNA-Dependent Polymerases: Evolutionary and Therapeutic Implications. PLoS One (2015) 0.84
Ebola virus disease. Can J Infect Dis Med Microbiol (2014) 0.84
Ebola Virus Infection: Overview and Update on Prevention and Treatment. Infect Dis Ther (2015) 0.83
Ebola virus disease and critical illness. Crit Care (2016) 0.82
Role of Marine Natural Products in the Genesis of Antiviral Agents. Chem Rev (2015) 0.82
Emerging antiviral resistant strains of influenza A and the potential therapeutic targets within the viral ribonucleoprotein (vRNP) complex. Virol J (2014) 0.82
Ebola virus disease: What clinicians in the United States need to know. Am J Infect Control (2015) 0.81
Molecular Basis for the Selective Inhibition of Respiratory Syncytial Virus RNA Polymerase by 2'-Fluoro-4'-Chloromethyl-Cytidine Triphosphate. PLoS Pathog (2015) 0.81
Clomiphene and Its Isomers Block Ebola Virus Particle Entry and Infection with Similar Potency: Potential Therapeutic Implications. Viruses (2016) 0.79
Favipiravir pharmacokinetics in non-human primates: insights for future efficacy studies of haemorrhagic fever viruses. Antimicrob Agents Chemother (2016) 0.79
Ebola Hemorrhagic Fever as a Public Health Emergency of International Concern; a Review Article. Emerg (Tehran) (2015) 0.79
Offering patients more: how the West Africa Ebola outbreak can shape innovation in therapeutic research for emerging and epidemic infections. Philos Trans R Soc Lond B Biol Sci (2017) 0.78
Pre-symptomatic diagnosis and treatment of filovirus diseases. Front Microbiol (2015) 0.77
Biochemical Evaluation of the Inhibition Properties of Favipiravir and 2'-C-Methyl-Cytidine Triphosphates against Human and Mouse Norovirus RNA Polymerases. Antimicrob Agents Chemother (2015) 0.77
Antiviral Activity of Favipiravir (T-705) against a Broad Range of Paramyxoviruses In Vitro and against Human Metapneumovirus in Hamsters. Antimicrob Agents Chemother (2016) 0.76
Broad-spectrum antiviral agents. Front Microbiol (2015) 0.76
Current Landscape of Antiviral Drug Discovery. F1000Res (2016) 0.76
Efficacy of Favipiravir (T-705) in Rabies Postexposure Prophylaxis. J Infect Dis (2015) 0.76
Ebola: Implications and Perspectives. Trans Am Clin Climatol Assoc (2015) 0.75
Ebola virus disease and the veterinary perspective. Ann Clin Microbiol Antimicrob (2015) 0.75
Therapeutics for postexposure treatment of Ebola virus infection. Future Virol (2015) 0.75
Influenza antivirals currently in late-phase clinical trial. Influenza Other Respir Viruses (2017) 0.75
Preventing the emergence of Ebola disease in unaffected countries: necessity of preparedness. Int J Health Policy Manag (2014) 0.75
Japanese Surveillance Systems and Treatment for Influenza. Curr Treat Options Infect Dis (2016) 0.75
Prophylactic Efficacy of Quercetin 3-β-O-d-Glucoside against Ebola Virus Infection. Antimicrob Agents Chemother (2016) 0.75
Ebola Viral Disease in West Africa: A Threat to Global Health, Economy and Political Stability. J Public Health Africa (2016) 0.75
Analysis of Ebola virus polymerase domains to find strain-specific differences and to gain insight on their pathogenicity. Virusdisease (2016) 0.75
Addressing Therapeutic Options for Ebola Virus Infection in Current and Future Outbreaks. Antimicrob Agents Chemother (2015) 0.75
Long-term Management of Panuveitis and Iris Heterochromia in an Ebola Survivor. Ophthalmology (2016) 0.75
Favipiravir pharmacokinetics in Ebola-Infected patients of the JIKI trial reveals concentrations lower than targeted. PLoS Negl Trop Dis (2017) 0.75
Ebola hemorrhagic fever: current outbreak and progress in finding a cure. Daru (2014) 0.75
Non-specific anti-viral approach towards Ebola virus infection: a comment on "Against Ebola: type I interferon guard risk and mesenchymal stromal cell combat sepsis". J Zhejiang Univ Sci B (2015) 0.75
Ebola Conquers West Africa - More to Come? EBioMedicine (2014) 0.75
Extinction of West Nile virus by Favipiravir through lethal mutagenesis. Antimicrob Agents Chemother (2017) 0.75
Repurposed Therapeutic Agents Targeting the Ebola Virus: A Systematic Review. Curr Ther Res Clin Exp (2017) 0.75
Characterization of Sudan Ebolavirus infection in ferrets. Oncotarget (2017) 0.75